Hepatitis C (englisch)

Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study, Hofmann et al., PLOS ONE | DOI:10.1371/journal.pone.0134839.

Zurück